基金经理：廖裕舟
| 最新价:-(-) | 涨跌幅:- | 涨跌额:- | 折溢价率:- | ||
|---|---|---|---|---|---|
| 单位净值:0.5947 | 净值增长率:0.34% | 累计净值:0.9668 | 截止日期:2025/1/24 | ||
| 最新规模:1.92亿元 | 风险等级:高风险 | 申购状态:不可申购 | 赎回状态:可赎回 |
展开全部
- 基本资料
- 投资风格
- 基金财务状况
- 基金评级
申万菱信中证申万医药生物指数A(163118)资产配置 |
|||||
|---|---|---|---|---|---|
| 报告日期 | 股票(元) | 债券(元) | 基金总资产(元) | 基金净值(元) | 股票占净值比 |
| 2024/12/31 | 210,793,000 | - | 226,428,000 | 225,336,000 | 94% |
| 2024/9/30 | 243,068,000 | - | 262,098,000 | 259,984,000 | 93% |
| 2024/6/30 | 206,300,000 | - | 221,917,000 | 220,924,000 | 93% |
| 2024/3/31 | 224,896,000 | - | 241,184,000 | 240,294,000 | 94% |
| 2023/12/31 | 250,090,000 | - | 267,882,000 | 266,806,000 | 94% |
| 2023/9/30 | 259,115,000 | - | 278,415,000 | 276,250,000 | 94% |
| 2023/6/30 | 260,364,000 | - | 279,876,000 | 278,474,000 | 94% |
| 2023/3/31 | 273,325,000 | - | 293,984,000 | 292,500,000 | 93% |
| 2022/12/31 | 275,392,000 | - | 295,902,000 | 293,913,000 | 94% |
| 2022/9/30 | 248,876,000 | - | 268,422,000 | 265,814,000 | 94% |
| 2022/6/30 | 259,565,000 | - | 278,923,000 | 277,296,000 | 94% |
| 2022/3/31 | 248,220,000 | - | 266,672,000 | 265,641,000 | 93% |
| 2021/12/31 | 263,593,000 | - | 282,612,000 | 281,616,000 | 94% |
| 2021/9/30 | 261,417,000 | - | 280,979,000 | 279,542,000 | 94% |
| 2021/6/30 | 291,082,000 | - | 316,775,000 | 312,462,000 | 93% |
| 2021/3/31 | 278,486,000 | - | 298,808,000 | 297,360,000 | 94% |
| 2021/1/18 | 307,405,000 | - | 331,817,000 | 327,233,000 | 94% |
*注：新浪财经提醒：以上数据由合作伙伴提供，仅供参考，交易请以正式公告数据为准。